Related Experiment Video
Updated: Aug 4, 2025

13:07
A Protocol for Transcranial Photobiomodulation Therapy in Mice
Published on: November 18, 2018
12.3K
Phototherapy improves cognitive function in dementia: A systematic review and meta-analysis
Xinlian Lu1, Chengyu Liu2, Feng Shao1
1School of Psychological and Cognitive Sciences, Peking University, Beijing, P. R. China.
Brain and Behavior
|April 5, 2023
Summary
Phototherapy significantly improved cognitive function in older adults with dementia, as measured by the Mini-Mental State Examination (MMSE) scores. This intervention did not show significant effects on behavioral symptoms or sleep quality.
Area of Science:
- Gerontology
- Neuroscience
- Photobiology
Background:
- Dementia significantly impacts cognitive function and quality of life in older adults.
- Current interventions for dementia have limitations, necessitating exploration of novel therapeutic approaches.
- Phototherapy presents a potential non-pharmacological intervention for managing dementia symptoms.
Approach:
- A systematic review and meta-analysis was conducted, searching multiple databases for relevant randomized controlled trials.
- Included studies focused on phototherapy interventions for patients diagnosed with dementia.
- The primary outcome assessed was cognitive function using the Mini-Mental State Examination (MMSE) score.
Key Points:
- Phototherapy interventions demonstrated a significant improvement in MMSE scores among dementia patients (MD 2.68, 95% CI: 1.38-3.98).
- No significant differences were observed in behavioral and psychological symptoms of dementia (BPSDs) or sleep parameters between phototherapy and control groups.
- The meta-analysis included 12 randomized controlled trials with a total of 766 participants.
Conclusions:
- Phototherapy is an effective intervention for enhancing cognitive function in individuals with dementia.
- Further research is warranted to explore the impact of phototherapy on BPSDs and sleep disturbances in dementia patients.
- This finding supports phototherapy as a potential adjunctive treatment for cognitive decline in dementia.
Related Concept Videos
Alzheimer's Disease: Treatment
232
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
232
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
172
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
172
Cognitive Development During Adulthood
178
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
178
Dementia
150
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
150

